SlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19Emerging Data on Hepatitis E | Christophe RodriguezView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19Practical/Clinical Considerations When Prescribing LA-ARVs | Monica GandhiView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19The Clinical Relevance of Integrase Resistance | Charlotte CharpentierView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19Clinical Relevance and Real Practice Use of HIV-1 NGS Results | Maria SantoroView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19Different Algorithms and Websites for Virus Evolution and Resistance Interpretation | Slim FouratiView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19HIV Prevention: Barriers and Facilitators of PrEP Access | Darrell H. S. TanView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19State-of-the-Art: RSV - Prevention & Treatment | Slim FouratiView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19Diagnosis Respiratory Viruses: Point-of-Care Testing & PCR | Carlo Federico PernoView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19Charles Boucher Lecture: The Düsseldorf Patient | Nadine LübkeView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19Andrea De Luca Lecture - Toxicity of Antiretroviral Drugs: What’s Important in 2023? | Laura WatersView Slideset
